MTD GROUP: AN INNOVATIVE SAFETY NEEDLE WITH FULLY PASSIVE MECHANISM, RECEIVED FDA CLEARANCE

2023-01-11
MILAN, Jan. 11, 2023 /PRNewswire/ --
MTD Group –a global leader in medical devices– today announced the
FDA clearance obtained by its affiliate Pikdare S.p.A. for DropSafeTM SicuraTM passive safety needle for the intramuscular and subcutaneous injection of vaccines and other drugs.
Safety needles are widely used by healthcare professionals (HCPs)
to avoid the risk of needlestick injuries (NSIs) when injecting drugs to patients. Despite broad introduction of safety regulations over the last decades, it is estimated that
more than 2 million NSIs still occur each year
[1].
"Moving towards safer medical device technology –and especially evolving sharps with injury prevention features to a more passive design– promises to reduce needlestick injuries. Safety device designs that require a user to actively do something can result in injury during activation, or failure to activate the safety feature at all. Truly passive designs can not only protect the user, but those downstream who may encounter that contaminated device as well" said Amber Mitchell, DrPH, MPH, CPH, President and Executive Director of the International Safety Center.
DropSafeTM SicuraTM is
designed to eliminate needlestick injuries providing a fully safe injection experience. The needle is
protected by a transparent shield
which automatically locks after injection, requiring no incremental activation step by the HCP post-injection.
The safety of HCPs has always been the top priority for the MTD Group, and the criticality of our mission has been further amplified in recent years with the spread of SARS-COV-2.
"Since the COVID pandemic began, vaccination effectiveness is a key global focus. A fully passive injection device such as the
DropSafeTM SicuraTM, fulfills an unmet need of our customers in the US for increased safety. We will immediately start to make the product available to pharmacy chains and the other practices that are fully focused in delivering care throughout the US", concluded
Carl Ward, General Manager of HTL Inc., the MTD Group company in North America.
This device is CE certification pending.
More product details: https://m.youtube.com/watch?v=ud2vvRlNVrY
MEDICAL TECHNOLOGY AND DEVICES
A leading med-tech group that designs, develops and provides globally a full range of medical devices for the professional sector and for home use. MTD was founded in 2018, when Pikdare and HTL-Strefa – two leading healthcare companies – joined forces.
[1] Bouya S, Balouchi A et al. Global Prevalence and Device Related Causes of Needle Stick Injuries among Health Care Workers: A Systematic Review and Meta-Analysis.2020;86(1):35
Logo - https://mma.prnewswire.com/media/1981366/MTD_Group_Logo.jpg
SOURCE MTD Group
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。